Becton Dickinson and Company

Stock Chart, Company Information, and Scan Results

$186.52(as of Sep 23, 3:59 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Becton Dickinson and Company Company Information, Fundamentals, and Technical Indicators

Stock Price$186.52
Ticker SymbolBDX
ExchangeNyse
SectorHealthcare
IndustryMedical Instruments & Supplies
Employees70,000
CountyUSA
Market Cap$53,610.8M
EBIDTA5,919.0M
10-Day Moving Average187.38
P/E Ratio33.53
20-Day Moving Average189.14
Forward P/E Ratio12.15
50-Day Moving Average186.91
Earnings per Share5.47
200-Day Moving Average200.46
Profit Margin10.42%
RSI45.89
Shares Outstanding286.6M
ATR3.33
52-Week High248.00
Volume1,225,867
52-Week Low161.47
Most Recent Support Level184.85
Book Value25,473.0M
Most Recent Resistance Level190.02
P/B Ratio2.11
Upper Keltner196.63
P/S Ratio2.52
Lower Keltner181.64
Debt-to-Equity Ratio196.63
Next Earnings Date11/06/2025
Cash Surplus-7,425.0M
Next Ex-Dividend DateUnknown

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation systems, and medication inventory optimization and tracking systems; hemodynamic monitoring systems; and prefillable drug delivery systems. The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.

Becton Dickinson and Company In Our Stock Scanner

As of Sep 24, 2025
example chart graphic
Scan Name: Increasing Profit MarginScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Falling WedgeScan Type: Chart Pattern Scans
As of ---
example chart graphic
Scan Name: Heikin Ashi BreakoutScan Type: Candlestick Pattern Scans
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.